Market Cap (In USD)
6.35 Million
Revenue (In USD)
104.28 Thousand
Net Income (In USD)
-1.2 Million
Avg. Volume
3437.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.031-1.37
- PE
- -2.65
- EPS
- -0.02
- Beta Value
- 0.905
- ISIN
- US9883661004
- CUSIP
- -
- CIK
- 895464
- Shares
- 119816000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Yang Wang
- Employee Count
- -
- Website
- https://www.yubogroup.com
- Ipo Date
- 2021-08-24
- Details
- Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is based in Beijing, China.
More Stocks
-
PRRSF
-
DCBODocebo Inc.
DCBO
-
TCLCONSTantia Constructions Limited
TCLCONS
-
BLDP
-
5035HOUSEI Inc.
5035
-
FMX
-
BEI-UN
-
MSON-BMidsona AB (publ)
MSON-B